[1]
N. Patel, J. Shah, A. Patel, and R. J. Patel, “Bioequivalence requirements of Pharmaceutical Products in US, Europe and Australia”, Int J Drug Reg Affairs, vol. 10, no. 2, pp. 56-61, Jun. 2022.